Skip to main content

Table 1 Baseline demographical and clinical characteristics in patients with low-energy distal radius fracture and controls who visited the osteoporosis centre at both inclusion and at one year follow up.

From: No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: a case-control study

 

Distal radius fracture

Controls

p*

 

n = 160

n = 169

 

Demographics

   

Age (years; mean (SD))

67 (9)

66 (9)

0.457

Females

144 (90)

151 (89)

0.846

BMI (kg/m2)

25.7 (4.3)

26.7 (4.3)

0.027

Menarche (years; mean (SD))

13.9 (1.5)

13.6 (1.4)

0.066

Menopause (years; mean (SD))

48.9 (4.5)

49.6 (4.1)

0.086

Education

  

0.011

< 10 years

56 (38)

70 (42)

 

11–13 years

61 (42)

45 (27)

 

> 13 years

30 (20)

53 (31)

 

Co-habiting

84(53)

112 (67)

0.011

Regular exercise**

119 (74)

126 (74)

0.970

Current smoker

23 (14)

21 (12)

0.604

Clinical characteristics

   

Current calcium and/or vitamin D treatment

39 (24)

41 (24)

0.981

Current ART

28 (18)

22 (13)

0.258

Previous fractures

83 (52)

77 (47)

0.319

≥ 1 fall in the previous year

68 (47)

48 (36)

0.054

Osteoporosis

52 (32)

30 (18)

<0.001

Osteopenia

83 (52)

74 (44)

 

Normal BMD

25 (16)

64 (38)

 

Heart diseases

48 (30)

58 (34)

0.402

Pulmonary diseases

19 (12)

12 (7)

0.138

Neurological diseases

12 (8)

14 (8)

0.792

Endocrine disorders

14 (9)

20 (12)

0.358

Gastrointestinal disorders

8 (5)

21 (12)

0.018

Urogenital disorders

5 (3)

1 (1)

0.086

Inflammatory joint disorders and connective tissue disorders

36 (23)

45 (26)

0.385

Cancer

16 (10)

19 (11)

0.715

Mental disorders

7 (4)

11 (7)

0.395

Co-morbidities (range 0–6)

1.0 (1.0)

1.2 (1.1)

0.191

  1. Mean (SD) for continuous variables and numbers (%) for categorical variables.
  2. *Bold p-values indicate significant differences between the groups
  3. ** Exercise more than 30 minutes three times a week.
  4. BMI, body mass index; ART, antiresorptive treatment, a specific osteoporosis treatment comprising biphosphonates, or selective oestrogen-receptor modulators.